Finerenone Archives - Medical Conferences

AHA Names 7 Cardiovascular Research Breakthroughs in 2024

Expert

Prof. Rachel Giles

Conference

AHA 2024

19 December 2024 11:40

FINEARTS-HF: Finerenone improves outcomes in heart failure with preserved ejection fraction

Presented By

Prof. Scott Solomon, Brigham and Women's Hospital, MA, USA

Trial

Phase 3, FINEARTS-HF

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 11:45

Heart failure: the 2023 update

Presented By

Prof. Theresa McDonagh; Prof. Roy Stuart Gardner; Prof. Alexandre Mebazaa; Prof. Ewa Jankowska; Prof. Marianna Adamo

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:05

FIDELITY: Cardiorenal benefits of finerenone, regardless of LVH status

Presented By

Prof. Gerasimos Filippatos , Attikon University Hospital, Greece

Trial

Phase 3, FIDELIO-DKD, FIGARO-DKD

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 12:09

Antagonising the mineralocorticoid receptor beneficial for patients with diabetes and CKD

Presented By

Prof. Bertram Pitt, University of Michigan School of Medicine, USA

Trial

Phase 3, FIGARO-DKD

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 12:40

Finerenone reduces the risk of AF onset in patients with CKD and diabetes

Presented By

Prof. Gerasimos Filippatos, Attikon University Hospital, Greece

Trial

Phase 3, FIDELIO-DKD

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 13:46

Finerenone lowers CV events in diabetic CKD patients

Presented By

Prof. Gerasimos Filippatos, National and Kapodistrian University of Athens, Greece

Trial

Phase 3, FIDELIO-DKD

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:33